Catalyst Wire Dossier Catalyst Wire Dossier

Leukoscan

Technetium-99m-sulesomab
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Leukoscan, covering 2017-06-20 to 2018-02-09. Get the full timeline:

Most recent: EMA Withdrawn: LeukoScan (sulesomab) — Immunomedics GmbH

See pricing